Back to Results
First PageMeta Content
Organochlorides / Organofluorides / Quinazolines / Tyrosine kinase receptors / Lapatinib / HER2/neu / Breast cancer / Triple-negative breast cancer / Apatinib / Chemistry / Organic chemistry / Aromatic amines


Researchers find new approach to treat drug-resistant HER2-positive breast cancer
Add to Reading List

Document Date: 2015-04-20 02:27:56

Open Document

File Size: 71,92 KB

Share Result on Facebook

Facility

University of North Carolina Health Care / /

IndustryTerm

therapy for HER2-positive breast cancer / /

MedicalCondition

leukemia / tumor / HER2-positive human cancer / cancer / tumors / triple-negative breast cancer / blood cancers / drug-resistant HER2-positive breast cancer / different HER2-positive breast cancer / drugresistant HER2-positive breast cancer / HER2-positive breast cancer / breast cancer / different ways HER2-positive cancer / human HER2-positive breast cancer / /

Organization

FDA / UNC School of Medicine Resistance / UNC School of Medicine / University of North Carolina / UNC Lineberger Comprehensive Cancer Center / University of North Carolina Health Care / /

Person

Tim Stuhlmiller / Gary Johnson / /

Position

senior author / first author / Professor and chair of the department / /

ProvinceOrState

North Carolina / /

Technology

gene expression / /

URL

www.tcpdf.org / http /

SocialTag